I am raising cash by selling stocks with more potential for a negative year and selling covered calls on retained stocks. Read more to see my thoughts...
Continue ReadingFund carefully manages its mega-cap exposure to promote diversification, control risk and promote long-term consistency, making it difficult to keep pace when the index is up 30%...
Continue ReadingThe fund outperformed the benchmark for the last quarter of 2024 primarily due to strong stock selection results, with selection in the United States notably positive. Read more here...
Continue ReadingSeeking Alpha contributors highlight 2025 investment picks. See why this article challenges you to avoid certain investments that may underperform...
Continue ReadingAs a result of stock selection and allocation decisions, the fund underperformed its benchmark as seven out of 11 equity sectors detracted. Read more here...
Continue ReadingTesla, Inc. plans to launch a $25K EV in 2025, expand energy production, and diversify revenue streams, but faces vulnerability. Click for my TSLA stock update...
Continue ReadingSMH's top holdings like Nvidia, Broadcom, and TSMC are well-positioned to partake in the next growth phase. Read why I maintain my buy rating for the fund...
Continue ReadingThe ProShares UltraPro QQQ ETF's underlying portfolio is trading at a nosebleed valuation, while the fund itself is levered to an extreme degree. Read more here...
Continue ReadingARKW is highly volatile, with significant exposure to Tesla & Bitcoin, comprising nearly quarter of its holdings. See why I downgrade the fund from buy to hold...
Continue ReadingPatient Capital Management's Opportunity Equity Strategy surpassed the market to end up 26.5%, 150bps ahead of the S&P 500âs 25.0%. Click here to read the full fund letter...
Continue Reading© 2026 Market News — All rights reserved